Agenus reported $308K in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US USD 5.02B 880M
Agenus AGEN:US USD 308K 1.72M
Amgen AMGN:US USD 1.59B 78M
AstraZeneca AZN:LN USD 2.12B 214M
Bristol Myers Squibb BMY:US USD 2.35B 324M
CSL CSL:AU USD 2.24B 355.8M
Dynavax Technologies DVAX:US USD 61.33M 22.04M
Eli Lilly And LLY:US USD 1.58B 148.6M
Gilead Sciences GILD:US USD 1.4B 47M
GlaxoSmithKline GSK:LN GBP 2.39B 250M
Glaxosmithkline GSK:US GBP 2.39B 250M
Intrexon XON:US USD 1.58M 234K
Jiangsu Hengrui Me. 600276:CH CNY 980.82M 148.19M
Johnson & Johnson JNJ:US USD 7.81B 95M
Karyopharm Therapeutics KPTI:US USD 980K 41K
MacroGenics MGNX:US USD 3.14M 741K
Merck MRK:GR EUR 2.15B 38M
Merk MRK:US USD 3.43B 715M
Novartis NOVN:VX USD 3.66B 92M
Novavax NVAX:US USD 434.59M 163.52M
Pfizer PFE:US USD 6.09B 2.58B
Regeneron Pharmaceuticals REGN:US USD 317.8M 20.7M
Rigel Pharmaceuticals RIGL:US USD 250K 786K
Veracyte VCYT:US USD 26.01M 978K
YTE INCY:US USD 49.28M 4.05M